Phibro Animal Health Q1 FY2024 Earnings: November 2023 Results

Phibro Animal Health Corporation reported fiscal year 2024 first-quarter financial results for the period ended September 30, 2023, with Animal Health sales and adjusted EBITDA growth of 4% and 6% respectively. The company updated full-year guidance with net sales projected between $980 million and $1.020 billion and adjusted EBITDA of $106 million to $112 million. Key growth drivers include vaccines (+14% sales), nutritional specialties (+3%), and continued investments in manufacturing capacity and companion animal pipeline initiatives.